Guggenheim cuts Legence stock price target to $90 on valuation
Guggenheim reduced its price target for Legence Corp (NASDAQ:LGN) to $90 from $115, citing a more conservative valuation assessment, while maintaining a Buy rating. The firm updated its financial estimates for 2027 and 2028 following management discussions. Legence's shares have fallen 55% over six months, trading at $36.07. The company reported Q2 revenue of $1.262 billion, up from $599 million, but missed earnings expectations with an adjusted EPS of -$0.37.
How this was made
The 30-second read
Why it matters
Analyst target cut may trigger short‑term selling, but the revenue beat and AI demand could provide upside if margins recover.
Market read
Primary relevance is to LGN shareholders; limited spillover to sector peers.
What to watch
The strong revenue growth and AI demand could support a rebound if margins improve.
Background
The article reports a new analyst price‑target revision for Legence Corp (LGN) alongside its latest quarterly results.
Ticker impact
Guggenheim lowered LGN price target to $90 from $115 and highlighted the recent earnings miss and revenue beat.
likely downward pressure as investors reassess valuation
The target cut signals a more conservative view, which often leads to short-term sell pressure.
Market effects
May affect peer AI‑infrastructure and cloud hardware stocks as valuation expectations tighten.
Limited to US tech equities; no broader regional effect.
Low; primarily a US micro‑cap impact.
Counterpoint
Some investors may see the lower target as a buying opportunity given the stock's steep discount to historical multiples.
Key entities
- companyLegence Corp
US‑listed AI‑infrastructure provider (NASDAQ:LGN).
- analyst_firmGuggenheim
Equity research firm that revised LGN's price target.
